# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-043354
Filing Date
2020-04-06
Accepted
2020-04-06 06:11:20
Documents
4
Period of Report
2020-04-23
Effectiveness Date
2020-04-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2014157-2_def14a.htm | DEF 14A | 361415
2 | GRAPHIC | lg_anchiano.jpg | GRAPHIC | 211754
3 | GRAPHIC | tm2014157d2-pc_meeting1.jpg | GRAPHIC | 523363
4 | GRAPHIC | tm2014157d2-pc_meeting2.jpg | GRAPHIC | 364423
| Complete submission text file | 0001104659-20-043354.txt |  | 1866620

Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38807 | Film No.: 20775657
SIC: 2834 Pharmaceutical Preparations